Status:

COMPLETED

Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Conditions:

Smoking Cessation

Tobacco Use Disorder

Eligibility:

All Genders

13-19 years

Phase:

PHASE2

PHASE3

Brief Summary

Currently one in five high school students smoke. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. Thi...

Detailed Description

Among adolescents, the short-term health effects of smoking include damage to the respiratory system, addiction to nicotine, and the associated risk of other drug use. Adolescents are at greater risk ...

Eligibility Criteria

Inclusion

  • Has smoked at least 5 cigarettes a day for at least 6 months
  • Does not regularly use other tobacco products
  • Motivated to quit smoking
  • Not currently using medications to quit smoking
  • Willing to use an effective form of contraception throughout the study

Exclusion

  • Informed that nicotine replacement therapy is medically inadvisable
  • Diagnosed with a psychiatric disorder within 3 months prior to enrollment
  • Currently taking an unstable dose of psychoactive medications
  • Currently taking medications that may react with a nicotine patch
  • History of alcohol or drug abuse within 3 months prior to enrollment
  • Pregnant

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2007

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00158158

Start Date

September 1 2005

End Date

September 1 2007

Last Update

January 10 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Minnesota

Minneapolis, Minnesota, United States, 55455